- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Polaroid reorganizes business groups
Polaroid's restructuring plan took a step forward last week whenthe Cambridge, MA, developer of photography and imaging productsreorganized itself into three business units. Those units arethe consumer, commercial, and new business groups, with
Polaroid's restructuring plan took a step forward last week whenthe Cambridge, MA, developer of photography and imaging productsreorganized itself into three business units. Those units arethe consumer, commercial, and new business groups, with PolaroidMedical Imaging Systems falling under the new business umbrella.The reorganization is part of Polaroid's restructuring plan, whichwas announced last month (SCAN 12/27/95).
PMIS, of Newton, MA, previously operated in Polaroid's highresolution division, which has been retired under the new reorganizationplan. The head of the new business group is Robert Delahunt, formerlysenior vice president of photographic imaging.
There were no other changes to the structure of PMIS underthe new plan, according to spokesperson Robert Guenther. The subsidiary'ssenior management team, headed by Gerald Knudson, remains in place,he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
